LabCorp
Financials
Estimates*
USD | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
---|---|---|---|---|---|---|---|
Revenues | 11.6b | 14.0b | 16.1b | 14.9b | 12.2b | 13.0b | 13.7b |
% growth | 2 % | 21 % | 15 % | (8 %) | (18 %) | 7 % | 6 % |
EBITDA | 2.0b | 3.5b | 4.1b | 2.7b | 1.7b | - | - |
% EBITDA margin | 17 % | 25 % | 26 % | 18 % | 14 % | - | - |
Profit | 824m | 1.6b | 2.4b | 1.3b | 418m | - | - |
% profit margin | 7 % | 11 % | 15 % | 9 % | 3 % | - | - |
Date | Investors | Amount | Round |
---|---|---|---|
- | N/A | - | |
N/A | N/A | IPO | |
* | N/A | $850m | Post IPO Debt |
* | N/A | $2.0b | Post IPO Debt |
Total Funding | - |
Related Content
Recent News about LabCorp
EditLabcorp is a global life sciences and healthcare company dedicated to advancing scientific research and improving human health. The company operates in the healthcare and life sciences market, providing a wide range of services that support the development and approval of medical products, including crop protection products. Labcorp serves a diverse client base, including pharmaceutical companies, biotechnology firms, and agricultural businesses.
Labcorp's business model is centered around offering comprehensive research and development (R&D) services. These services range from basic physicochemical testing to complex safety assessments and regulatory submissions. The company is particularly noted for its expertise in inhalation toxicology studies, which involve testing the safety of substances when inhaled. Labcorp's state-of-the-art facilities and dedicated inhalation testing rooms enable it to meet various regulatory requirements and handle complex substance aerosolization.
The company generates revenue by providing these specialized R&D services to its clients. By helping clients navigate the intricate landscape of national and regional regulations, Labcorp ensures that their products meet all necessary safety and efficacy standards. This not only accelerates the product development process but also increases the likelihood of regulatory approval, thereby driving client success and, in turn, Labcorp's profitability.
Labcorp's integrated approach and global presence, with over 60,000 employees worldwide, make it a unique player in the life sciences and healthcare industry. The company's commitment to scientific and operational continuity, from early-phase development to final product approval, underscores its mission to harness science for the greater good.
Keywords: life sciences, healthcare, R&D services, crop protection, inhalation toxicology, regulatory compliance, global presence, pharmaceutical, biotechnology, safety assessment.